Oruka Therapeutics (ORKA) Projected to Post Earnings on Thursday

Oruka Therapeutics (NASDAQ:ORKA) is expected to announce its earnings results before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of ($0.68) per share for the quarter.

Oruka Therapeutics Stock Performance

Shares of NASDAQ ORKA opened at $10.86 on Tuesday. The business has a fifty day moving average of $15.40. The stock has a market cap of $380.09 million, a price-to-earnings ratio of -1.73 and a beta of 0.77. Oruka Therapeutics has a one year low of $10.57 and a one year high of $53.88.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the stock. Wedbush reissued an “outperform” rating and set a $40.00 target price on shares of Oruka Therapeutics in a research note on Tuesday, November 19th. HC Wainwright reiterated a “buy” rating and set a $45.00 price objective on shares of Oruka Therapeutics in a research note on Friday, February 7th. Finally, Wolfe Research assumed coverage on Oruka Therapeutics in a research report on Tuesday, February 4th. They issued an “outperform” rating and a $20.00 target price on the stock. Seven analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $39.86.

About Oruka Therapeutics

Oruka Therapeutics, Inc is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.